Related Experiment Video
Updated: Jun 25, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation
Fabiana Oliveira1,2, Christina Papa1, Tobias Hagemann1
1Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany.
Abstract:
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for the treatment of depressive disorders. Recent clinical reports and studies in animal models have suggested that fluoxetine increases the risk of cardiovascular diseases, but the underlying mechanisms remain unknown. Here, we uncover that fluoxetine disrupts lipid and cholesterol metabolism in primary human endothelial cells (ECs). Fluoxetine triggered an upregulation of cholesterol metabolism genes, leading to the accumulation of lipid droplets in ECs. We find higher levels of cholesterol esters, ceramides, sphingolipids and fatty acids in ECs treated with fluoxetine. The disruption of lipid homeostasis was driven by increased cholesterol biosynthesis, as well as low-density lipoprotein (LDL) uptake and transcytosis via the LDL receptor. Fluoxetine accumulated in ECs in the endoplasmic reticulum (ER), caused ER expansion and reduced protein translation, without inducing ER stress markers. Mechanistically, fluoxetine activated the SREBP2 transcription factor in an INSIG-dependent manner. SREBP2 inhibition attenuated the fluoxetine-mediated upregulation of the LDL receptor and lipid accumulation. Our findings reveal that fluoxetine reprograms lipid metabolism and leads to endothelial dysfunction.
Insights
Fluoxetine disrupts lipid and cholesterol metabolism in human endothelial cells, leading to lipid accumulation and endothelial dysfunction. This study reveals new mechanisms linking this antidepressant to cardiovascular risks.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine are widely used for depression.
- Emerging evidence suggests a link between fluoxetine use and increased cardiovascular disease risk.
- The molecular mechanisms underlying this association are not well understood.
Purpose of the Study:
- To investigate the effects of fluoxetine on lipid and cholesterol metabolism in human endothelial cells (ECs).
- To elucidate the cellular mechanisms by which fluoxetine may contribute to endothelial dysfunction.
Main Methods:
- Primary human endothelial cells (ECs) were treated with fluoxetine.
- Gene expression analysis of cholesterol metabolism pathways.
- Measurement of intracellular lipid levels and lipid droplet accumulation.
- Assessment of low-density lipoprotein (LDL) receptor activity and transcytosis.
- Analysis of endoplasmic reticulum (ER) morphology and protein translation.
- Investigation of the role of SREBP2 transcription factor.
Main Results:
- Fluoxetine upregulated cholesterol metabolism genes and caused lipid droplet accumulation in ECs.
- Elevated levels of cholesterol esters, ceramides, sphingolipids, and fatty acids were observed.
- Fluoxetine enhanced cholesterol biosynthesis, LDL uptake, and transcytosis via the LDL receptor.
- Accumulation of fluoxetine in the ER led to ER expansion and reduced protein translation without inducing ER stress.
- Fluoxetine activated SREBP2 in an INSIG-dependent manner, promoting LDL receptor upregulation and lipid accumulation.
Conclusions:
- Fluoxetine disrupts lipid homeostasis in endothelial cells by reprogramming lipid metabolism.
- The drug activates the SREBP2 pathway, leading to increased cholesterol synthesis and LDL uptake.
- These metabolic changes contribute to endothelial dysfunction, potentially explaining the increased cardiovascular risk associated with fluoxetine.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Regulation of Nuclear Protein Sorting
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Lipid Catabolism